ДЕЯКІ ОСОБЛИВОСТІ КЛІТИННОГО ІМУНІТЕТУ ПРИ РІЗНИХ ПІДТИПАХ ІШЕМІЧНОГО ІНСУЛЬТУ В ГОСТРОМУ ПЕРІОДІ
DOI:
https://doi.org/10.11603/2415-8798.2013.4.6551Abstract
Вивчено вміст основних субпопуляцій Т-лімфоцитів при різних підтипах ішемічного інсульту (ІІ) в гострому періоді. Достовірно нижчі значення CD3+ та CD4+-лімфоцитів виявлено у хворих з атеротромботичним інсультом порівняно з іншими підтипами ІІ, CD8+ та CD16+-лімфоцитів при атеротромботичному та кардіоемболічному ІІ.
References
Herasymova M. M. Klynyko-ymmunolohycheskye aspekty tserebralʹnoho ynsulʹta / M. M. Herasymova, S. L. Medvedeva // Zhurn. nevrolohyy y psykhyatryy ym. S. S. Korsakova (prylozhenye “Ynsulʹt”). — 2003. — № 9. — S. 134.
Zhdanov H. N. Rolʹ ynterleykyna 1-a v patoheneze ostroho peryoda yshemycheskoho ynsulʹta / H. N. Zhdanov, M. M. Herasymova // Nevrolohycheskyy vestnyk. – 2005. – T. XXXVII, vyp. 1–2. – S. 18–21.
Sayko V. V. Kliniko-morfolohichne doslidzhennya pnevmoniy u hostromu periodi fatalʹnoho tserebralʹnoho ishemichnoho insulʹtu / V. V. Sayko, O. V. Sayko // Mezhdunarodnyy nevrolohycheskyy zhurnal. – 2012. – № 7 (53).
Sravnytelʹnoe yzuchenye ymmunokorrehyrueshcheho deystvyya neyropeptydnykh preparatov pry ostroy éksperymentalʹnoy tserebrovaskulyarnoy patolohy / A. E. Kulʹchykov, O. S. Molozhavaya, O. V. Skachkova [y dr.]// Tsytokyny y vospalenye. – 2009. – T.8, № 3. – S. 38–43.
Analysis of lymphocyte subsets in patients with stroke and their influence on infections after stroke / A. Vogelgesang, U. Grunwald, S. Lanrgren [et al.] // Stroke. – 2008. – Vol. 39. – P. 237–241.
Arumugam, T. V. Stroke and T-cells Neuromolecular / T. V. Arumugam, D. N. Granger, M. P. Mattson // Med. – 2005. – Vol. 7. – P. 229–242.
Becker K. J. Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab (R6.5) in acute stroke / K. J. Becker // Curr. Med. Res. Opin. – 2002. – Vol. 18, Suppl. 2. – P. 18–22.
Cytotoxic function of CD8+ T lymphocytes isolated from patients with acute severe cerebral infarction: an assessment of stroke-induced immunosuppression / G. Li, X. Wang, L. H. Huang [et al.] //BMC Immunol. – 2013. – Jan 3. – Vol. 14. – P. 1.
Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke / L. Zhang, Z. Zhang G., R. L. Zhang [et al.] // Stroke. – 2003. Vol. 34. – P. 1790–1795.
Harms and benefits of lymphocyte subpopulations in patients with acute stroke. / X. Urra, A. Cervera, N. Villamor [et al.] //Neuroscience. – 2009. – Vol. 158, № 3. – P. 1174–1183.
Herrmann M. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein / M. Herrmann, P. Vos, M. T. Wunderlich // Stroke. – 2000. – Vol. 31. – P. 2670–2677.
Immune activation in the peripheral blood of patients with acute ischemic stroke / J. Yan, J. M. Greer, K. Etherington [et al.] //J Neuroimmunol. – 2009, Jan. 3. – Vol. 206(1-2). – P. 112–117.
Impaired function of innate T lymphocytes and NK cells in the acute phase of ischemic stroke. / A. Peterfalvi, T. Molnar, M. Banati [et al.] //Cerebrovasc Dis. – 2009. – Vol. 28(5). – P. 490–498.
T cells contribute to stroke-induced lymphopenia in rats / L. Gu, X. Xiong, D. Wei [et al.] // PLoS One. – 2013. – Vol. 8(3). – P. 559–602.
Role of T-lymphocytes and interferon-g in ischemic stroke / G. Yilmaz, T. V. Arumugam, K. Y. Stokes, D. N. Granger // Circulation. – 2006. – Vol. 113. – P. 2105–2112.
Downloads
Published
How to Cite
Issue
Section
License
Authors who sent their manuscript to "Вісник наукових досліджень. Bulletin of Scientific Research" Surgery agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
